2 studies found for:    "Urachal cancer"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Cabozantinib for Advanced Urothelial Cancer
Conditions: Micropapillary Cancer of the Bladder;   Squamous Cell Carcinoma of the Bladder;   Bladder Cancer With Bone Metastases;   Bladder Cancer;   Small Cell Cancer of the Bladder;   Urachal Cancer;   Sarcomatoid Bladder Cancer
Interventions: Drug: Cabozantinib;   Procedure: FDG PET CT;   Procedure: NaF PET CT
2 Active, not recruiting Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
Conditions: Bladder Cancer;   Urethral Cancer;   Urachal Cancer
Interventions: Drug: 5-Fluorouracil (5-FU);   Drug: Leucovorin;   Drug: Cisplatin;   Drug: Gemcitabine

Indicates status has not been verified in more than two years